Mumbai, September 24 (Udaipur Kiran News): Shares of Poly Medicure traded higher on Wednesday after the company announced that its wholly owned step-down subsidiary RisoR Holdings B.V., Amsterdam has completed the acquisition of a 90% stake in the PendraCare Group from Wellinq Holdings B.V., Netherlands. The stock was quoting at Rs 1,966.80, up 0.86% from its previous close of Rs 1,950.00 on the BSE.
The counter opened at Rs 1,968.95 and touched an intraday high of Rs 1,985.50 and a low of Rs 1,942.40. A total of 2,977 shares were traded during the session. The company’s market capitalisation stands at Rs 19,900.88 crore.
Over the past year, the scrip has touched a 52-week high of Rs 3,350.00 (November 1, 2024) and a 52-week low of Rs 1,822.65 (August 13, 2025). On a weekly basis, it has traded between Rs 2,109.90 and Rs 1,933.00.
As per the shareholding pattern, promoters hold 62.44%, institutions 23.13%, and non-institutional investors 14.44%.
With the acquisition, Wellinq Medical B.V. and PendraCare Holding B.V. have become step-down subsidiaries of Poly Medicure. Earlier, the company had signed definitive agreements to acquire the stake at an enterprise value of €18.3 million.
Poly Medicure is one of India’s leading medical devices manufacturers and exporters, with a growing international presence.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.